A meta-analysis of quality-of-life estimates for stroke

Researchers performing cost-effectiveness analyses often incorporate quality-of-life (QOL) estimates. To aid analysts, we performed a meta-analysis to estimate quality of life for minor, moderate, and major stroke and assessed the relative importance of study design characteristics in predicting the...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:PharmacoEconomics 2003, Vol.21 (3), p.191-200
Hauptverfasser: TENGS, Tammy O, LIN, Ting H
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 200
container_issue 3
container_start_page 191
container_title PharmacoEconomics
container_volume 21
creator TENGS, Tammy O
LIN, Ting H
description Researchers performing cost-effectiveness analyses often incorporate quality-of-life (QOL) estimates. To aid analysts, we performed a meta-analysis to estimate quality of life for minor, moderate, and major stroke and assessed the relative importance of study design characteristics in predicting the quality of life of patients with stroke. Through a systematic search we identified 20 articles reporting 53 unique QOL weights for stroke. Each article was read and QOL weights and study characteristics were recorded. We used a hierarchical linear model (HLM) to perform a meta-regression. The model included severity of stroke, elicitation method, respondents, and QOL scale bounds as explanatory variables. Severity of stroke (p < 0.0001) and the bounds of the scale (p = 0.0015) were significant predictors of quality of life, while the elicitation method and respondents were not. Pooling QOL weights using the HLM model, we estimated a quality of life of 0.52 for major stroke, 0.68 for moderate stroke, and 0.87 for minor stroke if the time trade-off method is used to assess quality of life from community members when the scale bounds range from death to perfect health. We found no systematic difference in stroke QOL weights depending on elicitation method or respondents. However, quality of life is sensitive to the bounds of the scale. Because the pooled QOL estimates reported here are based on a comprehensive review of the QOL literature for stroke, they should be of great use to researchers performing cost-utility analyses of interventions designed to prevent or treat stroke, or where stroke is a possible side effect of therapy.
doi_str_mv 10.2165/00019053-200321030-00004
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_72989186</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>72989186</sourcerecordid><originalsourceid>FETCH-LOGICAL-c505t-bc0879724072fe77e6dab6747d6511e019296a37d2efe525887974a32fdb60eb3</originalsourceid><addsrcrecordid>eNpFkMtOwzAQRS0Eorx-AWUDO8PYju14iRBPVWIDa8tJxmpo0gQ7BfXvcWiBxXhGo3NH15eQjMEVZ0peAwAzIAXlAIIzEEDTCvI9csSYNmnN9f7PDFQrAzNyHON7IpTQ_JDMGJeyyJU5Ivom63B01K1cu4lNzHqffaxd24wb2nvaNh4zjGPTuRFj5vuQxTH0SzwlB961Ec92_YS83d-93j7S-cvD0-3NnFYS5EjLCgptNM9Bc49ao6pdqXSuayUZw_QLbpQTuuboUXJZTHTuBPd1qQBLcUIut3eH0H-skxPbNbHCtnUr7NfRam4KwwqVwGILVqGPMaC3Q0iuw8YysFNo9jc0-xea_QktSZ-30oADVn-6r-ViWGDVr-ynFY6z9GymIalTa1JNfUjFDJuO2sXYpWPnO8PrssP638Uu8gRc7AAXK9f64FZVE_-5XBZgtBTfdl6LqQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>72989186</pqid></control><display><type>article</type><title>A meta-analysis of quality-of-life estimates for stroke</title><source>MEDLINE</source><source>RePEc</source><source>SpringerLink Journals</source><creator>TENGS, Tammy O ; LIN, Ting H</creator><creatorcontrib>TENGS, Tammy O ; LIN, Ting H</creatorcontrib><description>Researchers performing cost-effectiveness analyses often incorporate quality-of-life (QOL) estimates. To aid analysts, we performed a meta-analysis to estimate quality of life for minor, moderate, and major stroke and assessed the relative importance of study design characteristics in predicting the quality of life of patients with stroke. Through a systematic search we identified 20 articles reporting 53 unique QOL weights for stroke. Each article was read and QOL weights and study characteristics were recorded. We used a hierarchical linear model (HLM) to perform a meta-regression. The model included severity of stroke, elicitation method, respondents, and QOL scale bounds as explanatory variables. Severity of stroke (p &lt; 0.0001) and the bounds of the scale (p = 0.0015) were significant predictors of quality of life, while the elicitation method and respondents were not. Pooling QOL weights using the HLM model, we estimated a quality of life of 0.52 for major stroke, 0.68 for moderate stroke, and 0.87 for minor stroke if the time trade-off method is used to assess quality of life from community members when the scale bounds range from death to perfect health. We found no systematic difference in stroke QOL weights depending on elicitation method or respondents. However, quality of life is sensitive to the bounds of the scale. Because the pooled QOL estimates reported here are based on a comprehensive review of the QOL literature for stroke, they should be of great use to researchers performing cost-utility analyses of interventions designed to prevent or treat stroke, or where stroke is a possible side effect of therapy.</description><identifier>ISSN: 1170-7690</identifier><identifier>EISSN: 1179-2027</identifier><identifier>DOI: 10.2165/00019053-200321030-00004</identifier><identifier>PMID: 12558469</identifier><language>eng</language><publisher>Auckland: Adis International</publisher><subject>Biological and medical sciences ; Health Status ; Health technology assessment ; Humans ; Medical sciences ; Meta analysis ; Neurology ; Pharmacoeconomics ; Quality of Life ; Severity of Illness Index ; Stroke ; Stroke - classification ; Vascular diseases and vascular malformations of the nervous system</subject><ispartof>PharmacoEconomics, 2003, Vol.21 (3), p.191-200</ispartof><rights>2003 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c505t-bc0879724072fe77e6dab6747d6511e019296a37d2efe525887974a32fdb60eb3</citedby><cites>FETCH-LOGICAL-c505t-bc0879724072fe77e6dab6747d6511e019296a37d2efe525887974a32fdb60eb3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,4008,4024,27923,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=14580975$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12558469$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttp://econpapers.repec.org/article/wkhphecon/v_3a21_3ay_3a2003_3ai_3a3_3ap_3a191-200.htm$$DView record in RePEc$$Hfree_for_read</backlink></links><search><creatorcontrib>TENGS, Tammy O</creatorcontrib><creatorcontrib>LIN, Ting H</creatorcontrib><title>A meta-analysis of quality-of-life estimates for stroke</title><title>PharmacoEconomics</title><addtitle>Pharmacoeconomics</addtitle><description>Researchers performing cost-effectiveness analyses often incorporate quality-of-life (QOL) estimates. To aid analysts, we performed a meta-analysis to estimate quality of life for minor, moderate, and major stroke and assessed the relative importance of study design characteristics in predicting the quality of life of patients with stroke. Through a systematic search we identified 20 articles reporting 53 unique QOL weights for stroke. Each article was read and QOL weights and study characteristics were recorded. We used a hierarchical linear model (HLM) to perform a meta-regression. The model included severity of stroke, elicitation method, respondents, and QOL scale bounds as explanatory variables. Severity of stroke (p &lt; 0.0001) and the bounds of the scale (p = 0.0015) were significant predictors of quality of life, while the elicitation method and respondents were not. Pooling QOL weights using the HLM model, we estimated a quality of life of 0.52 for major stroke, 0.68 for moderate stroke, and 0.87 for minor stroke if the time trade-off method is used to assess quality of life from community members when the scale bounds range from death to perfect health. We found no systematic difference in stroke QOL weights depending on elicitation method or respondents. However, quality of life is sensitive to the bounds of the scale. Because the pooled QOL estimates reported here are based on a comprehensive review of the QOL literature for stroke, they should be of great use to researchers performing cost-utility analyses of interventions designed to prevent or treat stroke, or where stroke is a possible side effect of therapy.</description><subject>Biological and medical sciences</subject><subject>Health Status</subject><subject>Health technology assessment</subject><subject>Humans</subject><subject>Medical sciences</subject><subject>Meta analysis</subject><subject>Neurology</subject><subject>Pharmacoeconomics</subject><subject>Quality of Life</subject><subject>Severity of Illness Index</subject><subject>Stroke</subject><subject>Stroke - classification</subject><subject>Vascular diseases and vascular malformations of the nervous system</subject><issn>1170-7690</issn><issn>1179-2027</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>X2L</sourceid><recordid>eNpFkMtOwzAQRS0Eorx-AWUDO8PYju14iRBPVWIDa8tJxmpo0gQ7BfXvcWiBxXhGo3NH15eQjMEVZ0peAwAzIAXlAIIzEEDTCvI9csSYNmnN9f7PDFQrAzNyHON7IpTQ_JDMGJeyyJU5Ivom63B01K1cu4lNzHqffaxd24wb2nvaNh4zjGPTuRFj5vuQxTH0SzwlB961Ec92_YS83d-93j7S-cvD0-3NnFYS5EjLCgptNM9Bc49ao6pdqXSuayUZw_QLbpQTuuboUXJZTHTuBPd1qQBLcUIut3eH0H-skxPbNbHCtnUr7NfRam4KwwqVwGILVqGPMaC3Q0iuw8YysFNo9jc0-xea_QktSZ-30oADVn-6r-ViWGDVr-ynFY6z9GymIalTa1JNfUjFDJuO2sXYpWPnO8PrssP638Uu8gRc7AAXK9f64FZVE_-5XBZgtBTfdl6LqQ</recordid><startdate>2003</startdate><enddate>2003</enddate><creator>TENGS, Tammy O</creator><creator>LIN, Ting H</creator><general>Adis International</general><general>Springer Healthcare | Adis</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>DKI</scope><scope>X2L</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>2003</creationdate><title>A meta-analysis of quality-of-life estimates for stroke</title><author>TENGS, Tammy O ; LIN, Ting H</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c505t-bc0879724072fe77e6dab6747d6511e019296a37d2efe525887974a32fdb60eb3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><topic>Biological and medical sciences</topic><topic>Health Status</topic><topic>Health technology assessment</topic><topic>Humans</topic><topic>Medical sciences</topic><topic>Meta analysis</topic><topic>Neurology</topic><topic>Pharmacoeconomics</topic><topic>Quality of Life</topic><topic>Severity of Illness Index</topic><topic>Stroke</topic><topic>Stroke - classification</topic><topic>Vascular diseases and vascular malformations of the nervous system</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>TENGS, Tammy O</creatorcontrib><creatorcontrib>LIN, Ting H</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>RePEc IDEAS</collection><collection>RePEc</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>PharmacoEconomics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>TENGS, Tammy O</au><au>LIN, Ting H</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A meta-analysis of quality-of-life estimates for stroke</atitle><jtitle>PharmacoEconomics</jtitle><addtitle>Pharmacoeconomics</addtitle><date>2003</date><risdate>2003</risdate><volume>21</volume><issue>3</issue><spage>191</spage><epage>200</epage><pages>191-200</pages><issn>1170-7690</issn><eissn>1179-2027</eissn><abstract>Researchers performing cost-effectiveness analyses often incorporate quality-of-life (QOL) estimates. To aid analysts, we performed a meta-analysis to estimate quality of life for minor, moderate, and major stroke and assessed the relative importance of study design characteristics in predicting the quality of life of patients with stroke. Through a systematic search we identified 20 articles reporting 53 unique QOL weights for stroke. Each article was read and QOL weights and study characteristics were recorded. We used a hierarchical linear model (HLM) to perform a meta-regression. The model included severity of stroke, elicitation method, respondents, and QOL scale bounds as explanatory variables. Severity of stroke (p &lt; 0.0001) and the bounds of the scale (p = 0.0015) were significant predictors of quality of life, while the elicitation method and respondents were not. Pooling QOL weights using the HLM model, we estimated a quality of life of 0.52 for major stroke, 0.68 for moderate stroke, and 0.87 for minor stroke if the time trade-off method is used to assess quality of life from community members when the scale bounds range from death to perfect health. We found no systematic difference in stroke QOL weights depending on elicitation method or respondents. However, quality of life is sensitive to the bounds of the scale. Because the pooled QOL estimates reported here are based on a comprehensive review of the QOL literature for stroke, they should be of great use to researchers performing cost-utility analyses of interventions designed to prevent or treat stroke, or where stroke is a possible side effect of therapy.</abstract><cop>Auckland</cop><pub>Adis International</pub><pmid>12558469</pmid><doi>10.2165/00019053-200321030-00004</doi><tpages>10</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1170-7690
ispartof PharmacoEconomics, 2003, Vol.21 (3), p.191-200
issn 1170-7690
1179-2027
language eng
recordid cdi_proquest_miscellaneous_72989186
source MEDLINE; RePEc; SpringerLink Journals
subjects Biological and medical sciences
Health Status
Health technology assessment
Humans
Medical sciences
Meta analysis
Neurology
Pharmacoeconomics
Quality of Life
Severity of Illness Index
Stroke
Stroke - classification
Vascular diseases and vascular malformations of the nervous system
title A meta-analysis of quality-of-life estimates for stroke
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T13%3A13%3A37IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20meta-analysis%20of%20quality-of-life%20estimates%20for%20stroke&rft.jtitle=PharmacoEconomics&rft.au=TENGS,%20Tammy%20O&rft.date=2003&rft.volume=21&rft.issue=3&rft.spage=191&rft.epage=200&rft.pages=191-200&rft.issn=1170-7690&rft.eissn=1179-2027&rft_id=info:doi/10.2165/00019053-200321030-00004&rft_dat=%3Cproquest_cross%3E72989186%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=72989186&rft_id=info:pmid/12558469&rfr_iscdi=true